BRIEF published on 05/05/2025 at 09:10, 1 year 1 month ago BioNxt Solutions Secures Patent Acceptance from Eurasian Patent Organization Innovation Autoimmune Diseases Drug Delivery BioNxt Solutions Eurasian Patent
BRIEF published on 05/05/2025 at 09:10, 1 year 1 month ago BioNxt Solutions obtient l'acceptation de son brevet auprès de l'Organisation eurasienne des brevets Innovation Maladies Auto-immunes Solutions BioNxt Administration De Médicaments Brevet Eurasien
PRESS RELEASE published on 05/05/2025 at 09:05, 1 year 1 month ago BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization BioNxt Solutions Inc. announces acceptance of its first national level patent filing by Eurasian Patent Organization, covering sublingual drug delivery for neurodegenerative diseases BioNxt Solutions Inc. Patent Filing Neurodegenerative Diseases Sublingual Delivery Eurasian Patent Organization
BRIEF published on 05/02/2025 at 01:55, 1 year 1 month ago BioNxt Solutions Delays 2024 Annual Financial Statement Filing Management Cease Trade Order Healthcare Innovation Financial Statements Delay Annual Filings BioNxt Solutions
BRIEF published on 05/02/2025 at 01:55, 1 year 1 month ago BioNxt Solutions retarde le dépôt de ses états financiers annuels pour 2024 Dépôts Annuels Solutions BioNxt Retard Des États Financiers Innovation Dans Le Domaine Des Soins De Santé Ordonnance De Cessation D'opérations De La Direction
PRESS RELEASE published on 05/02/2025 at 01:50, 1 year 1 month ago BioNxt Solutions Announces Delay In Filing 2024 Annual Financial Statements BioNxt Solutions Inc. announces delay in filing annual financial statements for year ended December 31, 2024. Company working on completing filings by June 28, 2025, under management cease trade order Financial Statements Management Cease Trade Order BioNxt Solutions Inc. Delay Regulatory Authorities
BRIEF published on 04/23/2025 at 09:10, 1 year 2 months ago BioNxt Solutions Advances in MS Treatment Study Multiple Sclerosis Cladribine Drug Delivery Innovation BioNxt Solutions Bioequivalence Study
BRIEF published on 04/23/2025 at 09:10, 1 year 2 months ago BioNxt Solutions progresse dans une étude sur le traitement de la sclérose en plaques Sclérose En Plaques Cladribine Solutions BioNxt Étude De Bioéquivalence Innovation En Matière D'administration De Médicaments
PRESS RELEASE published on 04/23/2025 at 09:05, 1 year 2 months ago BioNxt Solutions Prepares for Human Bioequivalence Study For MS BioNxt Solutions Inc. reports advanced preparation for human bioequivalence study of BNT23001, a novel sublingual thin-film Cladribine formulation for Multiple Sclerosis treatment BioNxt Solutions Inc. Multiple Sclerosis Treatment Sublingual Thin-Film BNT23001 Human Bioequivalence Study
BRIEF published on 03/15/2025 at 00:05, 1 year 3 months ago BioNxt Solutions Closes Final Tranche of Convertible Debenture Offering Private Placement Convertible Debenture Warrants Financing BioNxt Solutions
Published on 06/24/2026 at 14:45, 3 hours 58 minutes ago Amdocs Selected by Three Scandinavia to Support Customer Engagement Transformation Across Nordic Markets
Published on 06/24/2026 at 14:00, 4 hours 43 minutes ago GameSquare and U.S. Army Partner for Soldier Showdown 8, Presented by USAA
Published on 06/24/2026 at 14:00, 4 hours 43 minutes ago Adcore Announces Voting Results from Annual Shareholders Meeting
Published on 06/24/2026 at 13:05, 5 hours 38 minutes ago Faraday Copper Reports Drill Results Including Near-Surface Copper Mineralization in the American Eagle Area
Published on 06/24/2026 at 18:25, 18 minutes ago Huawei Helps Global Carriers Monetize Tokens with Service-Network-Compute Integration
Published on 06/24/2026 at 18:25, 18 minutes ago Annual General Meeting of Highlight Event and Entertainment AG
Published on 06/24/2026 at 18:05, 38 minutes ago BOS GmbH & Co. KG: Admission of bonds to trading on the Luxembourg Stock Exchange
Published on 06/24/2026 at 18:00, 43 minutes ago KERLINK : Assemblée générale mixte des actionnaires du 23 juin 2026 Seconde convocation le 9 juillet 2026.
Published on 06/24/2026 at 17:45, 58 minutes ago Air Liquide poursuit son développement au Kazakhstan avec un investissement clé pour le complexe industriel de Silleno
Published on 06/24/2026 at 17:45, 58 minutes ago Air Liquide continues its long-term growth in Kazakhstan with a key investment to support Silleno's world-scale plant
